Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.48%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.38%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.15%ABBV+0.94%ASMLa-9.33%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%1816.HK+3.45%HD+0.70%3988.HK-1.13%BAC-3.15%GE-2.90%0857.HK-0.49%ORCL-8.49%UNH+2.84%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L-3.62%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.69%ORp-0.36%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CHFJPY0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%EURPLN0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+2.62%ETHUSD+77.41%USDTUSD+0.11%XRPUSD+64.83%SOLUSD+72.04%TRXUSDT+1.22%ZECUSDT+4.58%XMRUSDT+7.51%DOGEUSD+72.43%LINKUSD+1.11%XLMUSD+1.88%BCHUSDT+2.52%LTCUSD+64.72%UNIUSD+5.47%TONUSD+74.91%SUIUSD-0.60%HBARUSDT+0.39%TAOUSDT+2.81%AAVEUSD-0.47%ONDOUSDT-0.45%DOTUSDT-2.05%ICPUSDT-6.44%WLDUSDT-0.52%ARBUSDT-1.08%ATOMUSDT-4.00%INJUSDT-4.62%STXUSDT+2.91%PYTHUSDT+0.51%TIAUSDT-1.31%FETUSDT-3.51%SEIUSDT-1.94%JUPUSDT-4.27%GRTUSDT+0.44%OPUSDT+0.63%IOTAUSDT-1.74%POLUSDT-0.14%WIFUSDT-2.78%AXSUSDT+0.75%EOSUSDT+0.62%IMXUSDT-3.33%FARTCOINUSDT-0.27%GALAUSDT-2.18%DYDXUSDT-3.92%ORDIUSDT-0.39%NOTUSDT-1.52%RONINUSDT+0.62%AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.48%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.38%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.15%ABBV+0.94%ASMLa-9.33%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%1816.HK+3.45%HD+0.70%3988.HK-1.13%BAC-3.15%GE-2.90%0857.HK-0.49%ORCL-8.49%UNH+2.84%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L-3.62%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.69%ORp-0.36%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CHFJPY0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%EURPLN0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+2.62%ETHUSD+77.41%USDTUSD+0.11%XRPUSD+64.83%SOLUSD+72.04%TRXUSDT+1.22%ZECUSDT+4.58%XMRUSDT+7.51%DOGEUSD+72.43%LINKUSD+1.11%XLMUSD+1.88%BCHUSDT+2.52%LTCUSD+64.72%UNIUSD+5.47%TONUSD+74.91%SUIUSD-0.60%HBARUSDT+0.39%TAOUSDT+2.81%AAVEUSD-0.47%ONDOUSDT-0.45%DOTUSDT-2.05%ICPUSDT-6.44%WLDUSDT-0.52%ARBUSDT-1.08%ATOMUSDT-4.00%INJUSDT-4.62%STXUSDT+2.91%PYTHUSDT+0.51%TIAUSDT-1.31%FETUSDT-3.51%SEIUSDT-1.94%JUPUSDT-4.27%GRTUSDT+0.44%OPUSDT+0.63%IOTAUSDT-1.74%POLUSDT-0.14%WIFUSDT-2.78%AXSUSDT+0.75%EOSUSDT+0.62%IMXUSDT-3.33%FARTCOINUSDT-0.27%GALAUSDT-2.18%DYDXUSDT-3.92%ORDIUSDT-0.39%NOTUSDT-1.52%RONINUSDT+0.62%
NE

NeoGenomics, Inc. (NEO)

NASDAQ • Healthcare

$14.82
-$0.26 (-1.8%)
Market closed

Last close at November 20, 2026 at 21:00 UTC

Open$14.86
Day Range$14.63 - $15.14
Avg. Volume (3M)1.6M
Market Cap$1.9B
52 Week Range
$7.07$20.15
Next EarningsIn 87 daysFeb 16, 2027

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$209.2M100%
Gross Profitminus cost of goods$96.5M46%

In plain terms: out of every $100 in revenue, NeoGenomics, Inc. currently loses $4.

Fundamentals & Financials

Revenue (TTM)
$787.7M
Net Income (TTM)
-$32.2M
EPS (TTM)
-$0.25
ROA (TTM)
-2.35%
Current Ratio
3.53
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+73.0%Q2 2026$0.01
+49.0%Q3 2026$0.05
+26.2%Q4 2026$0.07
Next

Feb 16

in 87 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +26.2%

NeoGenomics beat expectations on revenue in the second fiscal quarter of 2026, reported July 28, 2026, with revenue up 11.2% to about $201.7 million (from roughly $181.3 million a year ago) as its cancer-focused testing and research services business continued to expand across Clinical Services and Pharma Services. On the consensus comparison, revenue of $201.7 million topped the $196.9 million estimate, +2.4%. Gross profit came in at about $91.9 million, translating to a gross margin of roughly 46%, while profitability remained negative at the operating line with operating income of about -$9.8 million and an operating margin of around -5%. Adjusted EPS was $0.05, up from $0.03 a year ago. The company generated operating cash flow of about $20.0 million during the quarter and repurchased roughly $22.7 million of stock. For the next period, consensus calls for EPS of $0.06 on revenue of $205.9 million.

View full earnings history

About NeoGenomics, Inc.

NeoGenomics, Inc. provides cancer-focused diagnostic testing and research services within healthcare, operating in the medical diagnostics and research business. Listed on the NASDAQ as NEO, it generated $727.3 million of revenue in FY2025 through laboratory testing for patient care and services that support drug-development programs.

Name
NeoGenomics, Inc.
CEO
Anthony Zook
Industry
Healthcare
Year Founded
2001
Employees
2,500

Today's Snapshot

AI-generated

NEO closed 1.8% below yesterday's close, while its sector was flat.

Trading Volume

Below 10d avg (1.4M)

1.1M

vs S&P 500 Today

Outperforming Market

+1.70%

Updated: November 20, 2026 at 21:13 UTC

Technical Indicators

2 Buy1 Neutral5 Sell
NEO shows near-term weakness that contrasts with a higher long-term level, as the current price of 14.82 sits below the short and medium moving averages but above the 200-day averages, indicating longer-term support while recent momentum is negative. Momentum indicators including CCI and MACD are bearish and RSI is lowish in the mid-30s, while ADX near 20 suggests the directional trend lacks strong conviction. ATR implies moderate volatility and OBV points to selling pressure, with the pivot overhead. Technical takeaway: Sell — short-term weakness outweighs limited trend strength.
All signals
  • EMA (5 indicators)$13.96 - $16.63
    Sell
  • RSI (14)34.25
    Neutral
  • Stochastic %K (14, 3, 3)9.17
    Buy
  • MACD Level (12, 26)-0.55
    Sell
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.